Table 2.
Comparative analysis of demographic and clinical characteristics between PD patients tested at the first and the second rounds
| PD patients of the first round (n = 43) | PD patients of the second round (n = 23) | P value | |
|---|---|---|---|
| Age at diagnosis, years | 66 (59–70) | 70 (61–75) | 0.14 |
| Sex female/male | 15/28 | 7/16 | 0.79 |
| Age at onset, years | 65 (57–69) | 68 (60–71) | 0.24 |
| Interval between clinical diagnosis and NS, months | 2 (1–12) | 2 (1–12) | 0.99 |
| MDS-UPDRS III score | 20 (12–32) | 18 (9–33) | 0.95 |
| MoCA score | 26 (24–29) | 24 (24–28) | 0.11 |
| RT-QuIC-positive NSAN (%) | 27/32 (84) | 18/23 (78) | – |
| RT-QuIC-positive NSMT (%) | 5/11 (45) | 10/23 (43) | – |
Data are shown as median (IQR) or n (%)